VANCOUVER, Canada and
HOUSTON, Texas, Nov. 8, 2021 /CNW/ - ESSA Pharma Inc.
("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage
pharmaceutical company focused on developing novel therapies for
the treatment of prostate cancer, today announced that David R. Parkinson, President and Chief
Executive Officer of ESSA Pharma, will participate in and host
one-on-one meetings at three upcoming virtual investor conferences.
Peter Virsik, ESSA's Chief Operating
Officer, and David S. Wood, ESSA's
Chief Financial Officer, will also be participating in the
one-on-one meetings.
Presentation Details
Event: Jefferies London Healthcare Conference
Format (on-demand): Fireside Chat
Date: Thursday, November 18, 2021
Time: 8:00 a.m. GMT / 3:00 a.m.
ET
Event: Piper Sandler
33rd Annual Healthcare Conference
Format (on-demand): Fireside Chat
Date: Monday, November 22, 2021
Time: 10 a.m. ET
Event: Evercore ISI 4th Annual HealthCONx
Virtual Conference
Format (on-demand): Fireside Chat
Date: Thursday, December 2, 2021
Time: 1:50 p.m. ET
Webcasts of the events can be accessed in the Investors/Events
& Presentations section of ESSA's website at
www.essapharma.com. Following the events, the webcasts will be
archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage
pharmaceutical company focused on developing novel and proprietary
therapies for the treatment of patients with prostate cancer. For
more information, please visit www.essapharma.com and follow
us on Twitter under @ESSAPharma.
View original
content:https://www.prnewswire.com/news-releases/essa-pharma-to-participate-in-three-upcoming-investor-conferences-301418273.html
SOURCE ESSA Pharma Inc